Claim by researcher of injecting iPS cells into heart failure patients found to be fraudulent

October 15, 2012 by Bob Yirka weblog

(Medical Xpress)—Shortly after it was announced that Japanese researcher Shinya Yamanaka had won the Nobel Prize in Physiology or Medicine for his work in seeking alternatives to embryonic cells for use in stem cell research, fellow Japanese researcher Hisashi Moriguchi claimed that he and a team had injected iPS cells into the hearts of six human patients at Harvard Medical Center. Now it appears that such claims were false. In a recent press conference, Moriguchi changed his story and insisted that the procedure had taken place at a Boston hospital, and that just one patient was involved, not six – the other five were still in the planning stages.

In changing his story, Moriguchi also stated that he had lied in his initial account. That version was published by Japan's biggest newspaper Yomiuri Shimbun which also stated that Moriguchi had received permission for the procedure from Harvard Medical School's Institutional Review Board (IRB). The IRB has stated that no such permission was given, nor was any such procedure performed.

The revelations about Moriguchi have caused reporters and the editors of to investigate further his previous research and publications. In so doing they have found discrepancies in published reports of claims he's made, papers that list his name as author, and affiliations he has claimed as part of his work. In one instance, he was quoted by the newspaper Nihon Keizai Shimbun as stating that he had used iPS to treat Hepatitis patients. In another instance, officials from Massachusetts General Hospital (MGH) reported that one of its staff members was listed in the first reference as an author of a paper submitted by Moriguchi. No evidence has been found that Moriguchi conducted any iPS treatment of Hepatitis patients, and the staff member at MGH says he never worked with Moriguchi. In addition, officials from Harvard have gone on record as saying that Moriguchi has not worked at any of their affiliated hospitals since a brief stint as a visiting fellow at MGH in 2000.

Moriguchi also claimed in a short correspondence printed in Hepatology in 2010, that he had devised a new way to create iPS cells, using just two chemicals, work that has not been verified and Nature's news blog has pointed out that images Moriguchi used in publications seem "remarkably similar" to images on the Advanced Fertility Center of Chicago's web site.

In light of mounting evidence suggesting Moriguchi has been engaging in fraudulent activities, Yomiuri Shimbun printed a front page apology over its announcement heralding Moriguchi's achievement and at the end of his latest press conference, Moriguchi conceded that his career is likely over.

Explore further: Japan team create liver from stem cells: report

Related Stories

Japan team create liver from stem cells: report

June 8, 2012
Japanese researchers have created a functioning human liver from stemcells, a report said Friday, raising hopes for the manufacture of artificial organs for those in need of transplants.

Modest Nobel laureate says Japan deserves his prize

October 8, 2012
Japanese stem cell pioneer Shinya Yamanaka responded modestly after winning the Nobel prize for medicine Monday, saying his country really deserves the award.

Recommended for you

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

Large variety of microbial communities found to live along female reproductive tract

October 18, 2017
(Medical Xpress)—A large team of researchers from China (and one each from Norway and Denmark) has found that the female reproductive tract is host to a far richer microbial community than has been thought. In their paper ...

Study of what makes cells resistant to radiation could improve cancer treatments

October 18, 2017
A Johns Hopkins University biologist is part of a research team that has demonstrated a way to size up a cell's resistance to radiation, a step that could eventually help improve cancer treatments.

New approach helps rodents with spinal cord injury breathe on their own

October 17, 2017
One of the most severe consequences of spinal cord injury in the neck is losing the ability to control the diaphragm and breathe on one's own. Now, investigators show for the first time in laboratory models that two different ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

New method to measure how drugs interact

October 17, 2017
Cancer, HIV and tuberculosis are among the many serious diseases that are frequently treated with combinations of three or more drugs, over months or even years. Developing the most effective therapies for such diseases requires ...


Adjust slider to filter visible comments by rank

Display comments: newest first

3 / 5 (2) Oct 15, 2012
" the end of his latest press conference, Moriguchi conceded that his career is likely over." Maybe the first honest thing he said.
This type of lying is becoming more prevalent in science publishing. The reason is that the people doing the false reports are dishonest people.
5 / 5 (1) Oct 15, 2012
1. Publish or perish puts a lot of pressure on researchers.

2. As the bubble of scientific knowledge expands, individual scientists are becoming increasingly detached from what that bubble contains, and hence are increasingly incapable of policing others.

3. The reduction in policing capacity provides an opportunity for some to cheat.
2.3 / 5 (3) Oct 15, 2012
Dear people with heart disease.
I am sorry but I may have mislead you a touch about how far along my research was. In fact, I may have lied my a** off. I hope I didn't get your hopes raised too high, which I almost certainly did. No hard feelings.
3 / 5 (2) Oct 15, 2012
What does Shinya Yamanaka have to do with this story other than that he's Japanese? If he hasn't co-authored a paper with Moriguchi, or at the very least hasn't worked in the same lab, he shouldn't have his name besmirched here.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.